Boston Scientific (BSX) EV to EBITDA (2009 - 2026)

Boston Scientific has disclosed EV to EBITDA across 18 years of filings, most recently posting 52.25 for Q2 2026.

• In Q2 2026, EV to EBITDA fell 73.06% year-over-year to 52.25; the TTM figure through Jun 2026 stood at 14.83 (down 70.62% YoY), while the FY2025 annual figure was 38.68, down 23.39% from the prior year.
• EV to EBITDA came in at 52.25 for Q2 2026 at Boston Scientific, down from 83.61 in the prior quarter.
• In the past five years, EV to EBITDA ranged from a high of 212.95 in Q2 2024 to a low of 52.25 in Q2 2026.
• Average EV to EBITDA over 5 years is 146.27, with a median of 149.92 recorded in 2023.
• Year-over-year, EV to EBITDA jumped 49.57% in 2024 and sank 73.06% in 2026.
• Over 5 years, EV to EBITDA stood at 162.83 in 2022, then declined by 11.46% to 144.17 in 2023, then jumped by 35.07% to 194.73 in 2024, then retreated by 13.0% to 169.41 in 2025, then plunged by 69.15% to 52.25 in 2026.
• Per Business Quant data, the three most recent EV to EBITDA figures were 52.25 in Q2 2026, 83.61 in Q1 2026, and 169.41 in Q4 2025.